KLN Medical Expands Coronary Intervention Portfolio with APT Medical Deal
Event summary
- KLN Medical becomes the full-line distributor for APT Medical's coronary intervention products in Hong Kong, effective March 16, 2026.
- APT Medical's portfolio includes angiography triads, guiding catheters, PTCA guidewires, microcatheters, extension catheters, and PTCA balloons.
- KLN Medical will provide clinical training, after-sales support, and logistics services for APT Medical's products in Hong Kong.
- APT Medical's products are used in over 4,000 hospitals globally for vascular intervention as of the second half of 2024.
The big picture
This deal strengthens KLN Medical's position as a key player in Hong Kong's medical device distribution market, while APT Medical gains a strategic local partner to expand its reach. The collaboration aligns with broader trends of specialized logistics providers partnering with medical device manufacturers to improve supply chain efficiency and product accessibility.
What we're watching
- Market Penetration
- How KLN Medical's local expertise will accelerate APT Medical's product adoption in Hong Kong.
- Supply Chain Efficiency
- Whether KLN's logistics infrastructure can enhance clinical operational efficiency for healthcare institutions.
- Revenue Growth
- The pace at which this partnership will contribute to KLN Medical's revenue growth in the interventional cardiology sector.
Related topics